Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
28.87
-0.65 (-2.20%)
At close: Mar 6, 2026, 4:00 PM EST
28.87
0.00 (0.00%)
After-hours: Mar 6, 2026, 4:02 PM EST
Rigel Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 294.02 | 179.28 | 115.78 | 115.74 | 138.74 | Upgrade
|
| Other Revenue | 0.27 | - | 1.1 | - | - | Upgrade
|
| Revenue | 294.28 | 179.28 | 116.88 | 115.74 | 138.74 | Upgrade
|
| Revenue Growth (YoY) | 64.15% | 53.38% | 0.98% | -16.57% | 27.73% | Upgrade
|
| Cost of Revenue | 52.92 | 42.03 | 31.63 | 62.02 | 66.32 | Upgrade
|
| Gross Profit | 241.37 | 137.25 | 85.25 | 53.72 | 72.42 | Upgrade
|
| Selling, General & Admin | 115.9 | 113.06 | 105.74 | 112.45 | 91.89 | Upgrade
|
| Operating Expenses | 115.9 | 113.06 | 105.74 | 112.45 | 91.89 | Upgrade
|
| Operating Income | 125.47 | 24.19 | -20.49 | -58.73 | -19.48 | Upgrade
|
| Interest Expense | -7.32 | -7.92 | -6.87 | -3.71 | -4.86 | Upgrade
|
| Interest & Investment Income | 3.68 | 2.09 | 2.27 | 0.68 | 0.05 | Upgrade
|
| EBT Excluding Unusual Items | 121.83 | 18.37 | -25.09 | -61.75 | -24.29 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | -1.32 | -3.52 | Upgrade
|
| Other Unusual Items | - | - | - | 4.5 | 10.5 | Upgrade
|
| Pretax Income | 121.83 | 18.37 | -25.09 | -58.57 | -17.31 | Upgrade
|
| Income Tax Expense | -245.2 | 0.88 | - | - | 0.61 | Upgrade
|
| Net Income | 367.02 | 17.49 | -25.09 | -58.57 | -17.91 | Upgrade
|
| Net Income to Common | 367.02 | 17.49 | -25.09 | -58.57 | -17.91 | Upgrade
|
| Net Income Growth | 1999.08% | - | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 18 | 18 | 17 | 17 | 17 | Upgrade
|
| Shares Outstanding (Diluted) | 19 | 18 | 17 | 17 | 17 | Upgrade
|
| Shares Change (YoY) | 6.52% | 1.64% | 2.07% | -0.00% | 1.03% | Upgrade
|
| EPS (Basic) | 20.40 | 0.99 | -1.44 | -3.44 | -1.05 | Upgrade
|
| EPS (Diluted) | 19.48 | 0.99 | -1.44 | -3.44 | -1.05 | Upgrade
|
| EPS Growth | 1867.68% | - | - | - | - | Upgrade
|
| Free Cash Flow | 75.66 | 31.44 | -5.74 | -74.21 | 5.25 | Upgrade
|
| Free Cash Flow Per Share | 4.02 | 1.78 | -0.33 | -4.35 | 0.31 | Upgrade
|
| Gross Margin | 82.02% | 76.56% | 72.94% | 46.41% | 52.20% | Upgrade
|
| Operating Margin | 42.63% | 13.49% | -17.53% | -50.74% | -14.04% | Upgrade
|
| Profit Margin | 124.72% | 9.75% | -21.47% | -50.61% | -12.91% | Upgrade
|
| Free Cash Flow Margin | 25.71% | 17.53% | -4.91% | -64.11% | 3.79% | Upgrade
|
| EBITDA | 127.88 | 26.42 | -19.25 | -57.73 | -18.31 | Upgrade
|
| EBITDA Margin | 43.45% | 14.74% | -16.47% | -49.88% | -13.20% | Upgrade
|
| D&A For EBITDA | 2.42 | 2.23 | 1.24 | 1 | 1.16 | Upgrade
|
| EBIT | 125.47 | 24.19 | -20.49 | -58.73 | -19.48 | Upgrade
|
| EBIT Margin | 42.63% | 13.49% | -17.53% | -50.74% | -14.04% | Upgrade
|
| Effective Tax Rate | - | 4.80% | - | - | - | Upgrade
|
| Revenue as Reported | 294.28 | 179.28 | 116.88 | 120.24 | 149.24 | Upgrade
|
| Advertising Expenses | 2.3 | 2.1 | 3.1 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.